Healthcare -
Biotechnology - NASDAQ - US
$ 3.4
-0.293 %
$ 651 M
Market Cap
-8.29
P/E
ABUS - REVENUE
Revenue ABUS - Arbutus Biopharma Corporation
6.17 M
LAST VALUE
-60.23%
2 YEAR CAGR
0.53%
5 YEAR CAGR
-8.50%
10 YEAR CAGR